Rentokil Initial plc (RTO) has announced the commencement of a share buyback programme of up to USD 200 million, with purchases set to run until no later than 24 February 2027. The global pest control and hygiene services company has appointed Goldman Sachs International to execute the purchases independently across multiple UK trading venues. The programme follows Rentokil Initial's third quarter trading update covering the period 1 July 2026 to 30 September 2026, announced on 22 October 2026, and is intended to reduce the company's issued share capital whilst also meeting employee share scheme obligations.

Key Points

  • Rentokil Initial plc (RTO) — global leader in Pest Control and Hygiene & Wellbeing services, operating in 90 countries with approximately 63,400 employees
  • The company has launched a share buyback programme with an aggregate value of up to USD 200 million, executed through Goldman Sachs International
  • Purchases commence immediately and must conclude no later than 24 February 2027; the maximum shares authorised for repurchase under the 2026 AGM authority is 252,000,000
  • Investors should watch for regulatory announcements confirming individual share purchases, due within seven daily market sessions of each transaction

Goldman Sachs International to Execute USD 200 Million Buyback Independently Across London and European Venues

Under the terms of the programme, Rentokil Initial has instructed Goldman Sachs International to purchase ordinary shares acting as principal, with trading decisions made independently of the company regarding timing. Purchases will be conducted across the London Stock Exchange, Cboe Europe Limited through its BXE and CXE order books, Aquis Stock Exchange, and Turquoise. Shares acquired by Goldman Sachs International will then be on-sold to Rentokil Initial, with the company's direct purchases from Goldman Sachs carried out on the London Stock Exchange. This structure is designed to ensure the programme operates in accordance with market abuse regulations.

Buyback Authorised Under AGM 2026 Shareholder Approval Covering Up to 252 Million Ordinary Shares

The programme operates within the general authority granted to Rentokil Initial by shareholders at its Annual General Meeting on 7 May 2026, under which the maximum number of shares the company is authorised to repurchase is 252,000,000. The programme must also comply with Chapter 9 of the Financial Conduct Authority's UK Listing Rules and retained EU Market Abuse Regulation provisions incorporated into UK domestic law via the European Union (Withdrawal) Act 2018. Regulatory announcements confirming purchases will be made to shareholders no later than the end of the seventh daily market session following each transaction date.

Capital Reduction and Employee Share Scheme Obligations Drive Rentokil Initial's Buyback Rationale

The announcement states that the dual purpose of the programme is to reduce Rentokil Initial's issued share capital and to meet obligations under the company's employee share schemes. Shares purchased may be cancelled outright or held in treasury and subsequently used to satisfy future employee share scheme commitments. Rentokil Initial, which employs approximately 63,400 people across 90 countries providing pest control and hygiene and wellbeing services, has positioned the buyback as a capital management tool following its most recent quarterly trading update. Investors may be watching for further detail on the pace and scale of purchases as regulatory disclosures emerge.